IPP Bureau
Ajanta Pharma receives USFDA for Topiramate Extended Release Capsules
By IPP Bureau - August 31, 2023
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Mankind Pharma launches 120 premium DMF quality drugs for Indian Patients
By IPP Bureau - August 30, 2023
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
GarbhaGudi IVF Centre launches ‘Ghar Ghar Garbhagudi' campaign
By IPP Bureau - August 30, 2023
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ
By IPP Bureau - August 30, 2023
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Novo Nordisk, Eli Lilly record growth in Q2 driven by obesity, diabetes drug sales
By IPP Bureau - August 30, 2023
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
CK Birla Hospital signs MoU Intuitive for robotic-assisted surgery
By IPP Bureau - August 30, 2023
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
By IPP Bureau - August 29, 2023
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
By IPP Bureau - August 29, 2023
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Thermo Fisher Scientific launches ‘Made in India’ TSV Series lab refrigerators and freezers
By IPP Bureau - August 29, 2023
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
Apollo’s Apollo Connect program bets big on expanding access and elevating care
By IPP Bureau - August 29, 2023
Aims to build the largest connected healthcare ecosystem in India
Global Hospitals Parel Mumbai completes 100 successful robotic surgeries
By IPP Bureau - August 29, 2023
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
Briefs: Granules India
By IPP Bureau - August 28, 2023
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Lupin receives approval from USFDA for Pirfenidone Tablets
By IPP Bureau - August 28, 2023
This product will be manufactured at Lupin's Pithampur facility in India
Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
By IPP Bureau - August 28, 2023
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
IBL Healthcare invests in KNISS Laboratories
By IPP Bureau - August 28, 2023
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
